Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX7 | Q99572 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | GOT1 | P17174 | 1/20 | 0.32 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12495184 | 0.80 | TAAR1 (0.41) | P2RX7CYP1A2GOT1SLC6A9 | |
| SCHEMBL28595047 | 0.77 | GOT1 (0.34) | P2RX7CYP1A2GOT1SLC6A9 | |
| SCHEMBL4252452 | 0.77 | CYP1A2 (0.40) | CYP1A2SLC6A9 | |
| SCHEMBL6691295 | 0.77 | HIF1A (0.43) | P2RX7CYP1A2 | |
| SCHEMBL4269628 | 0.76 | — | — | |
| SCHEMBL5763081 | 0.73 | SLC6A2 (0.45) | CYP1A2 | |
| SCHEMBL5762413 | 0.73 | SLC6A2 (0.45) | CYP1A2 | |
| SCHEMBL5762415 | 0.73 | SLC6A2 (0.45) | CYP1A2 | |
| SCHEMBL28748 | 0.72 | — | — | |
| SCHEMBL22849136 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040110787-A1 | Heteroaryl-ethanolamine derivatives as antiviral agents | PHARMACIA & UPJOHN COMPANY | 2004-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040110787-A1 | Heteroaryl-ethanolamine derivatives as antiviral agents | RPL35, ZC3HAV1, RPL5 | P2RX7 4348/4885CYP1A2 2386/4885GOT1 182/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.